Cited by 265Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthLipid metabolism and disorders

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Open access

Brinton, E A, Eisenberg, S, Breslow, J L·1994·Arteriosclerosis and Thrombosis: A Journal of Vascular Biology

Open this paper in CoChat — free account Open PDF

Abstract

High-density lipoprotein (HDL) cholesterol (HDL-C) levels are a strong inverse predictor of atherosclerosis risk, but the physiological determinants of HDL-C levels are poorly understood. We selected 57 human subjects (30 women and 27 men) with a broad range of HDL-C levels and performed turnover studies of apolipoprotein (apo)A-I and apoA-II, the two major apolipoproteins of HDL, to measure the fractional catabolic rate (FCR) and production or transport rate (TR) of these proteins. We also measured several other parameters known to correlate with HDL-C levels to test for their interrelations and to postulate mechanisms of regulation of HDL-C levels. As expected, the women had higher levels of HDL-C (56.7 +/- 21.4 versus 45.1 +/- 16.3 mg/dL, mean +/- SD; P = .03) and apoA-I (147 +/- 32 versus 126 +/- 29 mg/dL, P = .01) than men and did not differ in apoA-II levels (34.5 +/- 7.4 versus 33.3 +/- 7.5 mg/dL, P > .2). The FCR of apoA-I tended to be lower in the women (0.248 +/- 0.077 versus 0.277 +/- 0.069 pools/d, P = .1), although the difference was not statistically significant. The FCR of apoA-II was also lower (0.184 +/- 0.043 versus 0.216 +/- 0.056 pools/d, P = .02). In contrast, the apoA-I TR was equal in women and men (12.0 +/- 1.6 versus 12.1 +/- 2.8 mg/kg per day, P > .2), and there was a trend toward lower apoA-II TR in women (2.19 +/- .62 versus 2.61 +/- 1.06 mg/kg per day, P = .07). Linear regression analysis revealed a strong inverse correlation between HDL-C levels and the FCRs of apoA-I and apoA-II (r = -.81 and -.76, respectively; P < .0001 for both). In contrast, there was little or no association between HDL-C and the TRs of apoA-I and apoA-II (r = .06 and -.35, P = not significant and .01, respectively). In stepwise multiple linear regression analysis, apoA-I FCR alone accounted for 66% of the variability in HDL-C; two other variables accounted for an additional 7%. Due to the importance of apoA-I FCR, its determinants were sought among the remaining variables.(ABSTRACT TRUNCATED AT 400 WORDS)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.atv.14.5.707

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A biometric study of basal metabolism in man
Harris, J. A., & Benedict, F. G. (2014) · Medical Entomology and Zoology · Cited by 1,847
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212
Self-citation
The Theory of Tracer Experiments with 131I-Labelled Plasma Proteins
Matthews, C. M. E. (1957) · Physics in Medicine and Biology · doi:10.1088/0031-9155/2/1/305 · Cited by 831
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337
Insulin stimulation of adipose tissue lipoprotein lipase. Use of the euglycemic clamp technique.
Sadur, C. N., & Eckel, R. H. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110547 · Cited by 288
Transport of Very Low Density Lipoprotein Triglycerides in Varying Degrees of Obesity and Hypertriglyceridemia
Grundy, S. M., Mok, H. Y. I., Zech, L. A., Steinberg, D. H., & Berman, M. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109422 · Cited by 283
A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
Brinton, E. A., Eisenberg, S., & Breslow, J. L. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114405 · Cited by 258
Self-citation

Flagged first, then by citations

Show all 36 references

1 of the 36 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Miller NE. High density lipoprotein as a predictor of clinical coronary heart disease. In: Fidge NH, Nestel PJ, eds. Athero- sclerosis VII. Amsterdam, the Netherlands: Elsevier; 1986:61.
National Health and Nutrition Examination Survey. Dietary intake source data, 11. Hyattsville, Md: National Center for Health Statistics; Office of Health Research Statistics and Technology; 1983:48-52.
Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipo- protein lipase. J Clin Invest. 1982;69:1119-1125.

Sorted by citations

Items 201–264 of 264

Mass kinetics of apolipoprotein A-I in interstitial fluid after administration of intravenous apolipoprotein A-I/lecithin discs in humans
Hovorka, R., Nanjee, M. N., Cooke, C. J., Miller, I. P., Olszewski, W. L., & Miller, N. E. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500358-jlr200 · Cited by 13
Polymorphism in the Cholesteryl Ester Transfer Protein Gene and the Risk of Early Onset Myocardial Infarction among Cigarette Smokers
Goldenberg, I., Moss, A. J., Block, R., Ryan, D. H., Corsetti, J. P., McNitt, S. A., Eberly, S. W., & Zaręba, W. (2007) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2007.00186.x · Cited by 13
Cystatin C, CRP, Log TG/HDLc and Metabolic Syndrome are Associated with Microalbuminuria in Hypertension
Moura, R. D. S. D. S. E. S., Vasconcelos, D. F., Freitas, E., de Moura, F. J. D., Rosa, T. T., & Veiga, J. P. R. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130210 · Cited by 13
Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice
Kitayama, K., Nishizawa, T., Abe, K., Wakabayashi, K., Oda, T., Inaba, T., & Amemiya, Y. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.12.0010 · Cited by 12
HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function
Berisha, S. Z., Brubaker, G., Kasumov, T., Hung, K. T., DiBello, P. M., Huang, Y. R., Li, L., Willard, B. B., Pollard, K. A., Nagy, L. E., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m056754 · Cited by 11
Method and computer program for controlling the family-wise alpha rate in gene association studies involving multiple phenotypes
Allison, D. B., & Beasley, M. (1998) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1998)15:1 · Cited by 15
Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women
Welty, F. K., Lichtenstein, A. H., Lamon‐Fava, S., Schaefer, E. J., & Marsh, J. B. (2007) · Metabolism · doi:10.1016/j.metabol.2007.01.022 · Cited by 10
Insulin Resistance and Dyslipidemia: Implications for Coronary Heart Disease Risk
Laws, A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-716-1_14 · Cited by 10
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion Protein
Regenass-Lechner, F., Staack, R. F., Mary, J.-L., Richter, W., Winter, M., Jordan, G., Justies, N., Langenkamp, A., Garrido, R., Albassam, M., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw004 · Cited by 9
Determinants of HDL particle size in patients with the null (P207L) or defective (D9N) mutation in the lipoprotein lipase gene: the Québec LipD Study
Ruel, I. L., Gaudet, D., Perron, P., Pascot, A., Després, J., Bergeron, J., Julien, P., & Lamarche, B. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00716-x · Cited by 9
Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: Improvement by 17β-estradiol
Westerveld, H. T., Meijer, E., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90154-7 · Cited by 8
Serum HDL cholesterol values are associated with apoB-containing lipoprotein metabolism and triglyceride-body fat interrelation in young Japanese men
Kazumi, T. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06049-2 · Cited by 8
Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects
Jia, L., Wu, X., Fu, M., Xu, Y., Tian, Y., Tian, H., & Tian, L. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.04.017 · Cited by 8
Characterization of woodchuck apolipoprotein A‐I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model
Fioravanti, J., Gomar, C., Medina‐Echeverz, J., Otano, I., Benito, A., Prìeto, J., González‐Aseguinolaza, G., & Berraondo, P. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22104 · Cited by 7
Modulatory effect of berberine on plasma lipoprotein (or lipid) profile: a review
Nourizadeh, N., Mostaan, L. V., Saburi, E., & Hashemy, S. I. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07623-7 · Cited by 6
A polymorphism of the cholesterol ester transfer protein gene predicts cardiovascular events in non-smokers in the west of scotland coronary prevention study
Freeman, D. J., Samani, N. J., & Wilson, V. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.019 · Cited by 6
Sex differences in the central and peripheral omega 3 oxylipin response to acute systemic inflammation
Kelliher, J. C., Marić, I., Engeland, C. G., Shearer, G. C., & Skibicka, K. P. (2024) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00242.2024 · Cited by 4
No short‐term effect of oral isotretinoin (13‐cis retinoic acid) on lipoprotein(a) and HDL subclasses LP‐A‐I and LP‐A‐I:A‐II in healthy volunteers
Neele, D. M., Buytenhek, R., Staels, B., Dallongeville, J., Wallnöfer, A., Kooistra, T., & Princen, H. M. G. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00544.x · Cited by 5
PPAR-γ agonists, insulin resistance and dyslipidemia: not a simple relationship
Johns, B., & Reaven, G. M. (2010) · Clinical Lipidology · doi:10.2217/clp.10.36 · Cited by 5
High‐density lipoprotein apolipoprotein A‐I kinetics: comparison of radioactive and stable isotope studies
Ooi, E. M. M., Watts, G. F., Farvid, M. S., Chan, D. C., Allen, M. C., Zilko, S. R., & Barrett, P. H. R. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01708.x · Cited by 5
Chronic Hyperinsulinemia Does Not Increase the Production Rate of High-Density Lipoprotein Apolipoprotein AI
Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301597 · Cited by 5
LpAI in HDL subfractions: serum levels in men and women with coronary heart disease and changes under hypolipemic therapy
Nowicka, G., & Jarosz, A. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00389-8 · Cited by 4
Diabetes and Dyslipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_2 · Cited by 4
Syndrome X
Reaven, G. M. (1997) · Humana Press eBooks · doi:10.1007/978-1-4757-3906-0_19 · Cited by 4
Metabolic Syndrome
Reaven, G. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_2 · Cited by 3
Gender and age differences in the distribution of the HDL subclasses among the Chinese population
Tian, L., Yang, Y., Fu, M., & Xu, Y. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200900040 · Cited by 3
High-Density Lipoprotein Metabolism
Brewer, H. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00004-9 · Cited by 3
Effects of drugs on postprandial lipoprotein metabolism
Packard, C. J. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970075 · Cited by 3
Moderate Alcohol Consumption, Insulin Resistance, and Cardiovascular Disease
Reaven, G. M. (2000) · Medical science symposia series · doi:10.1007/978-94-011-4307-3_7 · Cited by 2
The Pancreas and Lipoprotein Metabolism
Ginsberg, H. N., & Goldberg, I. J. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070222 · Cited by 2
Nutritional Factors and High‐Density Lipoprotein Metabolism
Schaefer, E. J., Lamon‐Fava, S., & Asztalos, B. F. (2007) · Wiley eBooks · doi:10.1002/9783527625178.ch17 · Cited by 2
Cholesterol metabolism in type 2 diabetes
Simonen, P. P. (2002) · Työväentutkimus Vuosikirja · Cited by 2
Oxidative Stress and Risk of Cardiovascular Disease Associated with Low- and High-Monounsaturated Fat Portfolio Diets
Chiavaroli, L. (2010) · TSpace (University of Toronto) · Cited by 2
Diabetes and Dyslipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-4 · Cited by 2
Diabetes and Dislipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_2 · Cited by 1
Cistatina C, PCR, Log TG/HDLc e Síndrome Metabólica estão Relacionados a Microalbuminúria na Hipertensão Cystatin C, CRP, Log TG/HDLc and Metabolic Syndrome are Associated with Microalbuminuria in Hypertension
Souza, S., Moura, S., Vasconcelos, D. F., Freitas, E. D. S., Rosa, T. T., Paulo, J., & Veiga, R. (2013) · Cited by 1
[Action of androgens on fat distribution and metabolic balance].
Tostain, J.-B., Heim, M., & Rossi, D. (2004) · PubMed · Cited by 1
Diabetes and Dyslipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-3 · Cited by 1
ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease
Guo, X., Huang, Z., Chen, J., Hu, J., Hu, D., Peng, D., & Yu, B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.913363 · Cited by 1
Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid
Méndez‐Sánchez, N., Panduro, A., Murguía, D., Rincón‐Sánchez, A. R., & Uribe, M. (2002) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32180-5 · Cited by 1
The Clinical Relevance and Management of High-Density Lipoprotein Deficiency
Zlaket-Matta, G., Vela, B. S., & Brinton, E. A. (2001) · The Endocrinologist · doi:10.1097/00019616-200101000-00004 · Cited by 1
Self-citation
Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL
Schwarz, M., & Kim, J. B. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch8
Investigation of total HDL and HDL subclass kinetics using stable isotope techniques in healthy subjects
Wang, K. (2015) · Surrey Research Insight Open Access (The University of Surrey)
HDL kinetics, fish oils and diabetes
Barrett, P. H. R., & Watts, G. F. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00690-6
Low HDL Cholesterol: What Are the Prospects of Increasing It?
Ginsberg, H. N. (1995) · Annals of Medicine · doi:10.3109/07853899509002577
The high- and low-activity forms of human plasma phospholipid transfer protein (PLTP)
Jänis, M. T. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood
Nilsson, S. K. (2010)
Aus der Abteilung für Molekulare Zellbiologie des Instituts für Medizinische Biochemie und Molekularbiologie der Universitätskliniken Hamburg-Eppendorf
Beisiegel†, U. (2003)
ASPIRIN AND NICOTINIC ACID AS TWO FACES OF SAME COIN IN THE TREATMENT OF DYSLIPIDEMIA
Mutahar, R. M., & Dinesh, B. M. (2024) · International Research Journal of Pharmacy
Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients
Brinton, E. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_20
Self-citation
A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz‐Based Regimens
Homkham, N., Cressey, T. R., Ingsrisawang, L., Bouazza, N., Ngampiyaskul, C., Hongsiriwon, S., Srirojana, S., Kanjanavanit, S., Bhakeecheep, S., Cœur, S. L., et al. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.701
Efeito da dieta rica em colesterol e gordura saturada sobre o metabolismo da lipoproteína de alta densidade (HDL) em hamsters
Paulo, S. (2010)
Studies on lipoprotein kinetics in obesity and the metabolic syndrome: impact of dietary weight loss and statin therapy
Ng, T. (2007) · UWA Profiles and Research Repository (UWA)
The Future: Elevating High Density Lipoprotein
Paterniti, J. R., Damon, R. E., Eskesen, J. B., & Weinstein, D. B. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_67
Étude comparative de l'impact de la simvastatine et de l'atorvastatine, deux inhibiteurs de l'HMG-COA réductase, sur la cinétique in vivo de l'apolipoprotéine A-I chez l'homme
Mauger, J. (2004) · Corpus Université Laval (Université Laval)
Intraperitoneal Versus Subcutaneous Insulin Treatment in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis Therapy
Nevalainen, P. I. (2001) · Tampere University Institutional Repository (Tampere University)
HIGH-DENSITY LIPOPROTEINS AND APOLIPOPROTEIN A-I WITH AORTIC ENDOTHELIAL CELLS
Ohnsorg, P. M. (2011)
Diabetes and Dislipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-1
The Role of Liver X Receptors in Reverse Cholesterol Transport and Atherosclerosis
Breevoort, S. R. (2014) · doi:10.18130/v3925p
Diabetes and Dyslipidemia
Ginsberg, H. N., Khavandi, M., & Reyes‐Soffer, G. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_2-2
Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2
Brinton, E. A., & Pulipati, V. P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_24
Self-citation
The Pancreas and Lipoprotein Metabolism
Ginsberg, H. N., & Goldberg, I. J. (2001) · Comprehensive physiology · doi:10.1002/j.2040-4603.2001.tb01468.x
Association of Khat chewing and shisha smoking with metabolic syndrome and diabetes factors among Yemeni women
Hameed, D. A., Al-Maqtari, M. A., Al-Tahami, M. A., Saif-Ali, R., & Al-Arnoot, S. (2026) · Eclética Química · doi:10.26850/1678-4618.eq.v51.2026.e1675
Gene therapy for the genetic dyslipoproteinaemias
Brewer, H. B., Brown, D. R., Kashyap, V. S., Applebaum-Bowden, D. M., Hoeg, J. M., Maeda, N., & Santamarina-Fojo, S. (1995) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-6585-3_8

Authors: Brinton, E. A., Eisenberg, S., & Breslow, J. L.
Affiliations: Rockefeller University (US)
ORCID: Brinton, E A
Breslow, J L
Venue: Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1994-05
Volume: 14
Issue: 5
Pages: 707-720
ISSN: 1049-8834 (ISSN-L)
DOI: 10.1161/01.atv.14.5.707
OpenAlex: W2155588817
Cited by: 265
References: 36
Citations by year: 2026: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 9 · 2012: 3
FWCI: 16.95
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Pew Charitable Trusts
Memorial Sloan-Kettering Cancer Center
National Institutes of Health (5r01hl033714-17, 5r37hl036461-09)
National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL-36461, HL32435)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords: HDL cholesterol, apolipoprotein A-I, apolipoprotein A-II, fractional catabolic rate, HDL particle size, sex differences, hepatic lipase, lipoprotein lipase, triglycerides, insulin, body fat distribution, atherosclerosis risk
MeSH terms: Adipose Tissue, Adult, Aged, Female, Humans, Insulin, Lipase, Lipoprotein Lipase, Lipoproteins, HDL, Cholesterol, HDL, Liver, Male, Middle Aged, Particle Size, Regression Analysis, Sex Factors, Triglycerides, Apolipoprotein A-I, Apolipoprotein A-II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks